{"transactions":[{"id":2398404,"issuer":{"id":111217,"kind":"organization","name":"Applied UV, Inc.","symbol":"AUVI"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-14T15:18:29.000Z","date":"2021-01-01","kind":"purchase","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock vests January 1, 2022."}],"balance_after":35000,"source":{"system":"sec-edgar","filing":"0001607062-22-000101","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811109/000160706222000101/ownership.xml","form_type":"5"}},{"id":3252512,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-02-24T19:32:23.000Z","date":"2020-02-20","kind":"disposition_to_issuer","acquired":false,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each Dermira restricted stock unit (\"RSU\"), whether vested or unvested, was canceled and converted into the right to receive an amount of cash equal to the product of (x) the number of Shares underlying such Dermira RSU multiplied by (y) the Offer Price."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\") dated January 10, 2020, by and among Dermira, Inc. (\"Dermira\"), Eli Lilly and Company, an Indiana corporation (\"Lilly\"), and Bald Eagle Acquisition Corporation, a Delaware corporation and a wholly owned subsidiary of Lilly (\"Merger Sub\"), Merger Sub merged with and into Dermira, with Dermira surviving as a wholly owned subsidiary of Lilly (the \"Merger\"), effective as of February 20, 2020.  Pursuant to the Merger Agreement, each issued and outstanding share (the \"Shares\") of Dermira common stock, par value $0.001 per share, was purchased at a price of $18.75 per share (the \"Offer Price\"), net to the seller in cash, without interest, and subject to withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each Dermira restricted stock unit (\"RSU\"), whether vested or unvested, was canceled and converted into the right to receive an amount of cash equal to the product of (x) the number of Shares underlying such Dermira RSU multiplied by (y) the Offer Price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each Dermira restricted stock unit (\"RSU\"), whether vested or unvested, was canceled and converted into the right to receive an amount of cash equal to the product of (x) the number of Shares underlying such Dermira RSU multiplied by (y) the Offer Price."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each Dermira restricted stock unit (\"RSU\"), whether vested or unvested, was canceled and converted into the right to receive an amount of cash equal to the product of (x) the number of Shares underlying such Dermira RSU multiplied by (y) the Offer Price."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001562180-20-001621","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218020001621/primarydocument.xml","form_type":"4"}},{"id":3252511,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-02-24T19:32:23.000Z","date":"2020-02-20","kind":"disposition_to_issuer","acquired":false,"shares":5700,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each Dermira stock option, whether vested or unvested, was canceled and converted into the right to receive an amount in cash equal to the product of (x) the number of Shares issuable under such option multiplied by (y) the excess, if any, of (A) the Offer Price over (B) the per share exercise price of such option.  Any outstanding Dermira stock options with an exercise price equal to or greater than the Offer Price were canceled for no consideration at the Effective Time."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\") dated January 10, 2020, by and among Dermira, Inc. (\"Dermira\"), Eli Lilly and Company, an Indiana corporation (\"Lilly\"), and Bald Eagle Acquisition Corporation, a Delaware corporation and a wholly owned subsidiary of Lilly (\"Merger Sub\"), Merger Sub merged with and into Dermira, with Dermira surviving as a wholly owned subsidiary of Lilly (the \"Merger\"), effective as of February 20, 2020.  Pursuant to the Merger Agreement, each issued and outstanding share (the \"Shares\") of Dermira common stock, par value $0.001 per share, was purchased at a price of $18.75 per share (the \"Offer Price\"), net to the seller in cash, without interest, and subject to withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each Dermira restricted stock unit (\"RSU\"), whether vested or unvested, was canceled and converted into the right to receive an amount of cash equal to the product of (x) the number of Shares underlying such Dermira RSU multiplied by (y) the Offer Price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each Dermira restricted stock unit (\"RSU\"), whether vested or unvested, was canceled and converted into the right to receive an amount of cash equal to the product of (x) the number of Shares underlying such Dermira RSU multiplied by (y) the Offer Price."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each Dermira restricted stock unit (\"RSU\"), whether vested or unvested, was canceled and converted into the right to receive an amount of cash equal to the product of (x) the number of Shares underlying such Dermira RSU multiplied by (y) the Offer Price."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5700},"source":{"system":"sec-edgar","filing":"0001562180-20-001621","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218020001621/primarydocument.xml","form_type":"4"}},{"id":3252510,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-02-24T19:32:23.000Z","date":"2020-02-20","kind":"disposition_to_issuer","acquired":false,"shares":2437,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each Dermira stock option, whether vested or unvested, was canceled and converted into the right to receive an amount in cash equal to the product of (x) the number of Shares issuable under such option multiplied by (y) the excess, if any, of (A) the Offer Price over (B) the per share exercise price of such option.  Any outstanding Dermira stock options with an exercise price equal to or greater than the Offer Price were canceled for no consideration at the Effective Time."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\") dated January 10, 2020, by and among Dermira, Inc. (\"Dermira\"), Eli Lilly and Company, an Indiana corporation (\"Lilly\"), and Bald Eagle Acquisition Corporation, a Delaware corporation and a wholly owned subsidiary of Lilly (\"Merger Sub\"), Merger Sub merged with and into Dermira, with Dermira surviving as a wholly owned subsidiary of Lilly (the \"Merger\"), effective as of February 20, 2020.  Pursuant to the Merger Agreement, each issued and outstanding share (the \"Shares\") of Dermira common stock, par value $0.001 per share, was purchased at a price of $18.75 per share (the \"Offer Price\"), net to the seller in cash, without interest, and subject to withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each Dermira restricted stock unit (\"RSU\"), whether vested or unvested, was canceled and converted into the right to receive an amount of cash equal to the product of (x) the number of Shares underlying such Dermira RSU multiplied by (y) the Offer Price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each Dermira restricted stock unit (\"RSU\"), whether vested or unvested, was canceled and converted into the right to receive an amount of cash equal to the product of (x) the number of Shares underlying such Dermira RSU multiplied by (y) the Offer Price."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each Dermira restricted stock unit (\"RSU\"), whether vested or unvested, was canceled and converted into the right to receive an amount of cash equal to the product of (x) the number of Shares underlying such Dermira RSU multiplied by (y) the Offer Price."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2437},"source":{"system":"sec-edgar","filing":"0001562180-20-001621","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218020001621/primarydocument.xml","form_type":"4"}},{"id":3252509,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Options (Right to buy)","published_at":"2020-02-24T19:32:23.000Z","date":"2020-02-20","kind":"disposition_to_issuer","acquired":false,"shares":65000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\") dated January 10, 2020, by and among Dermira, Inc. (\"Dermira\"), Eli Lilly and Company, an Indiana corporation (\"Lilly\"), and Bald Eagle Acquisition Corporation, a Delaware corporation and a wholly owned subsidiary of Lilly (\"Merger Sub\"), Merger Sub merged with and into Dermira, with Dermira surviving as a wholly owned subsidiary of Lilly (the \"Merger\"), effective as of February 20, 2020.  Pursuant to the Merger Agreement, each issued and outstanding share (the \"Shares\") of Dermira common stock, par value $0.001 per share, was purchased at a price of $18.75 per share (the \"Offer Price\"), net to the seller in cash, without interest, and subject to withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each Dermira stock option, whether vested or unvested, was canceled and converted into the right to receive an amount in cash equal to the product of (x) the number of Shares issuable under such option multiplied by (y) the excess, if any, of (A) the Offer Price over (B) the per share exercise price of such option.  Any outstanding Dermira stock options with an exercise price equal to or greater than the Offer Price were canceled for no consideration at the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each Dermira stock option, whether vested or unvested, was canceled and converted into the right to receive an amount in cash equal to the product of (x) the number of Shares issuable under such option multiplied by (y) the excess, if any, of (A) the Offer Price over (B) the per share exercise price of such option.  Any outstanding Dermira stock options with an exercise price equal to or greater than the Offer Price were canceled for no consideration at the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":7.42,"expiration_date":"2029-02-11","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001562180-20-001621","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218020001621/primarydocument.xml","form_type":"4"}},{"id":3252508,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Options (Right to buy)","published_at":"2020-02-24T19:32:23.000Z","date":"2020-02-20","kind":"disposition_to_issuer","acquired":false,"shares":57000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\") dated January 10, 2020, by and among Dermira, Inc. (\"Dermira\"), Eli Lilly and Company, an Indiana corporation (\"Lilly\"), and Bald Eagle Acquisition Corporation, a Delaware corporation and a wholly owned subsidiary of Lilly (\"Merger Sub\"), Merger Sub merged with and into Dermira, with Dermira surviving as a wholly owned subsidiary of Lilly (the \"Merger\"), effective as of February 20, 2020.  Pursuant to the Merger Agreement, each issued and outstanding share (the \"Shares\") of Dermira common stock, par value $0.001 per share, was purchased at a price of $18.75 per share (the \"Offer Price\"), net to the seller in cash, without interest, and subject to withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each Dermira stock option, whether vested or unvested, was canceled and converted into the right to receive an amount in cash equal to the product of (x) the number of Shares issuable under such option multiplied by (y) the excess, if any, of (A) the Offer Price over (B) the per share exercise price of such option.  Any outstanding Dermira stock options with an exercise price equal to or greater than the Offer Price were canceled for no consideration at the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each Dermira stock option, whether vested or unvested, was canceled and converted into the right to receive an amount in cash equal to the product of (x) the number of Shares issuable under such option multiplied by (y) the excess, if any, of (A) the Offer Price over (B) the per share exercise price of such option.  Any outstanding Dermira stock options with an exercise price equal to or greater than the Offer Price were canceled for no consideration at the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":28.25,"expiration_date":"2028-02-14","underlying":"Common Stock","underlying_shares":57000},"source":{"system":"sec-edgar","filing":"0001562180-20-001621","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218020001621/primarydocument.xml","form_type":"4"}},{"id":3252507,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Options (Right to buy)","published_at":"2020-02-24T19:32:23.000Z","date":"2020-02-20","kind":"disposition_to_issuer","acquired":false,"shares":48750,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\") dated January 10, 2020, by and among Dermira, Inc. (\"Dermira\"), Eli Lilly and Company, an Indiana corporation (\"Lilly\"), and Bald Eagle Acquisition Corporation, a Delaware corporation and a wholly owned subsidiary of Lilly (\"Merger Sub\"), Merger Sub merged with and into Dermira, with Dermira surviving as a wholly owned subsidiary of Lilly (the \"Merger\"), effective as of February 20, 2020.  Pursuant to the Merger Agreement, each issued and outstanding share (the \"Shares\") of Dermira common stock, par value $0.001 per share, was purchased at a price of $18.75 per share (the \"Offer Price\"), net to the seller in cash, without interest, and subject to withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each Dermira stock option, whether vested or unvested, was canceled and converted into the right to receive an amount in cash equal to the product of (x) the number of Shares issuable under such option multiplied by (y) the excess, if any, of (A) the Offer Price over (B) the per share exercise price of such option.  Any outstanding Dermira stock options with an exercise price equal to or greater than the Offer Price were canceled for no consideration at the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each Dermira stock option, whether vested or unvested, was canceled and converted into the right to receive an amount in cash equal to the product of (x) the number of Shares issuable under such option multiplied by (y) the excess, if any, of (A) the Offer Price over (B) the per share exercise price of such option.  Any outstanding Dermira stock options with an exercise price equal to or greater than the Offer Price were canceled for no consideration at the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":33.84,"expiration_date":"2027-02-16","underlying":"Common Stock","underlying_shares":48750},"source":{"system":"sec-edgar","filing":"0001562180-20-001621","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218020001621/primarydocument.xml","form_type":"4"}},{"id":3252506,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2020-02-24T19:32:23.000Z","date":"2020-02-20","kind":"disposition_to_issuer","acquired":false,"shares":52500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\") dated January 10, 2020, by and among Dermira, Inc. (\"Dermira\"), Eli Lilly and Company, an Indiana corporation (\"Lilly\"), and Bald Eagle Acquisition Corporation, a Delaware corporation and a wholly owned subsidiary of Lilly (\"Merger Sub\"), Merger Sub merged with and into Dermira, with Dermira surviving as a wholly owned subsidiary of Lilly (the \"Merger\"), effective as of February 20, 2020.  Pursuant to the Merger Agreement, each issued and outstanding share (the \"Shares\") of Dermira common stock, par value $0.001 per share, was purchased at a price of $18.75 per share (the \"Offer Price\"), net to the seller in cash, without interest, and subject to withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each Dermira stock option, whether vested or unvested, was canceled and converted into the right to receive an amount in cash equal to the product of (x) the number of Shares issuable under such option multiplied by (y) the excess, if any, of (A) the Offer Price over (B) the per share exercise price of such option.  Any outstanding Dermira stock options with an exercise price equal to or greater than the Offer Price were canceled for no consideration at the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each Dermira stock option, whether vested or unvested, was canceled and converted into the right to receive an amount in cash equal to the product of (x) the number of Shares issuable under such option multiplied by (y) the excess, if any, of (A) the Offer Price over (B) the per share exercise price of such option.  Any outstanding Dermira stock options with an exercise price equal to or greater than the Offer Price were canceled for no consideration at the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":26.37,"expiration_date":"2026-02-04","underlying":"Common Stock","underlying_shares":52500},"source":{"system":"sec-edgar","filing":"0001562180-20-001621","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218020001621/primarydocument.xml","form_type":"4"}},{"id":3252505,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Options (Right to buy)","published_at":"2020-02-24T19:32:23.000Z","date":"2020-02-20","kind":"disposition_to_issuer","acquired":false,"shares":9528,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\") dated January 10, 2020, by and among Dermira, Inc. (\"Dermira\"), Eli Lilly and Company, an Indiana corporation (\"Lilly\"), and Bald Eagle Acquisition Corporation, a Delaware corporation and a wholly owned subsidiary of Lilly (\"Merger Sub\"), Merger Sub merged with and into Dermira, with Dermira surviving as a wholly owned subsidiary of Lilly (the \"Merger\"), effective as of February 20, 2020.  Pursuant to the Merger Agreement, each issued and outstanding share (the \"Shares\") of Dermira common stock, par value $0.001 per share, was purchased at a price of $18.75 per share (the \"Offer Price\"), net to the seller in cash, without interest, and subject to withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each Dermira stock option, whether vested or unvested, was canceled and converted into the right to receive an amount in cash equal to the product of (x) the number of Shares issuable under such option multiplied by (y) the excess, if any, of (A) the Offer Price over (B) the per share exercise price of such option.  Any outstanding Dermira stock options with an exercise price equal to or greater than the Offer Price were canceled for no consideration at the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each Dermira stock option, whether vested or unvested, was canceled and converted into the right to receive an amount in cash equal to the product of (x) the number of Shares issuable under such option multiplied by (y) the excess, if any, of (A) the Offer Price over (B) the per share exercise price of such option.  Any outstanding Dermira stock options with an exercise price equal to or greater than the Offer Price were canceled for no consideration at the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":16,"expiration_date":"2024-10-01","underlying":"Common Stock","underlying_shares":9528},"source":{"system":"sec-edgar","filing":"0001562180-20-001621","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218020001621/primarydocument.xml","form_type":"4"}},{"id":3252504,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2020-02-24T19:32:23.000Z","date":"2020-02-20","kind":"disposition_to_issuer","acquired":false,"shares":16332,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\") dated January 10, 2020, by and among Dermira, Inc. (\"Dermira\"), Eli Lilly and Company, an Indiana corporation (\"Lilly\"), and Bald Eagle Acquisition Corporation, a Delaware corporation and a wholly owned subsidiary of Lilly (\"Merger Sub\"), Merger Sub merged with and into Dermira, with Dermira surviving as a wholly owned subsidiary of Lilly (the \"Merger\"), effective as of February 20, 2020.  Pursuant to the Merger Agreement, each issued and outstanding share (the \"Shares\") of Dermira common stock, par value $0.001 per share, was purchased at a price of $18.75 per share (the \"Offer Price\"), net to the seller in cash, without interest, and subject to withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each Dermira stock option, whether vested or unvested, was canceled and converted into the right to receive an amount in cash equal to the product of (x) the number of Shares issuable under such option multiplied by (y) the excess, if any, of (A) the Offer Price over (B) the per share exercise price of such option.  Any outstanding Dermira stock options with an exercise price equal to or greater than the Offer Price were canceled for no consideration at the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each Dermira stock option, whether vested or unvested, was canceled and converted into the right to receive an amount in cash equal to the product of (x) the number of Shares issuable under such option multiplied by (y) the excess, if any, of (A) the Offer Price over (B) the per share exercise price of such option.  Any outstanding Dermira stock options with an exercise price equal to or greater than the Offer Price were canceled for no consideration at the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":16,"expiration_date":"2024-10-01","underlying":"Common Stock","underlying_shares":16332},"source":{"system":"sec-edgar","filing":"0001562180-20-001621","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218020001621/primarydocument.xml","form_type":"4"}},{"id":3252503,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2020-02-24T19:32:23.000Z","date":"2020-02-20","kind":"disposition_to_issuer","acquired":false,"shares":103258,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\") dated January 10, 2020, by and among Dermira, Inc. (\"Dermira\"), Eli Lilly and Company, an Indiana corporation (\"Lilly\"), and Bald Eagle Acquisition Corporation, a Delaware corporation and a wholly owned subsidiary of Lilly (\"Merger Sub\"), Merger Sub merged with and into Dermira, with Dermira surviving as a wholly owned subsidiary of Lilly (the \"Merger\"), effective as of February 20, 2020.  Pursuant to the Merger Agreement, each issued and outstanding share (the \"Shares\") of Dermira common stock, par value $0.001 per share, was purchased at a price of $18.75 per share (the \"Offer Price\"), net to the seller in cash, without interest, and subject to withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each Dermira stock option, whether vested or unvested, was canceled and converted into the right to receive an amount in cash equal to the product of (x) the number of Shares issuable under such option multiplied by (y) the excess, if any, of (A) the Offer Price over (B) the per share exercise price of such option.  Any outstanding Dermira stock options with an exercise price equal to or greater than the Offer Price were canceled for no consideration at the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each Dermira stock option, whether vested or unvested, was canceled and converted into the right to receive an amount in cash equal to the product of (x) the number of Shares issuable under such option multiplied by (y) the excess, if any, of (A) the Offer Price over (B) the per share exercise price of such option.  Any outstanding Dermira stock options with an exercise price equal to or greater than the Offer Price were canceled for no consideration at the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":1.218,"expiration_date":"2023-01-03","underlying":"Common Stock","underlying_shares":103258},"source":{"system":"sec-edgar","filing":"0001562180-20-001621","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218020001621/primarydocument.xml","form_type":"4"}},{"id":3252502,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2020-02-24T19:32:23.000Z","date":"2020-02-20","kind":"disposition_to_issuer","acquired":false,"shares":32758,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\") dated January 10, 2020, by and among Dermira, Inc. (\"Dermira\"), Eli Lilly and Company, an Indiana corporation (\"Lilly\"), and Bald Eagle Acquisition Corporation, a Delaware corporation and a wholly owned subsidiary of Lilly (\"Merger Sub\"), Merger Sub merged with and into Dermira, with Dermira surviving as a wholly owned subsidiary of Lilly (the \"Merger\"), effective as of February 20, 2020.  Pursuant to the Merger Agreement, each issued and outstanding share (the \"Shares\") of Dermira common stock, par value $0.001 per share, was purchased at a price of $18.75 per share (the \"Offer Price\"), net to the seller in cash, without interest, and subject to withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each Dermira stock option, whether vested or unvested, was canceled and converted into the right to receive an amount in cash equal to the product of (x) the number of Shares issuable under such option multiplied by (y) the excess, if any, of (A) the Offer Price over (B) the per share exercise price of such option.  Any outstanding Dermira stock options with an exercise price equal to or greater than the Offer Price were canceled for no consideration at the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each Dermira stock option, whether vested or unvested, was canceled and converted into the right to receive an amount in cash equal to the product of (x) the number of Shares issuable under such option multiplied by (y) the excess, if any, of (A) the Offer Price over (B) the per share exercise price of such option.  Any outstanding Dermira stock options with an exercise price equal to or greater than the Offer Price were canceled for no consideration at the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":0.986,"expiration_date":"2022-02-08","underlying":"Common Stock","underlying_shares":32758},"source":{"system":"sec-edgar","filing":"0001562180-20-001621","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218020001621/primarydocument.xml","form_type":"4"}},{"id":3252501,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2020-02-24T19:32:23.000Z","date":"2020-02-20","kind":"disposition_to_issuer","acquired":false,"shares":110434,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\") dated January 10, 2020, by and among Dermira, Inc. (\"Dermira\"), Eli Lilly and Company, an Indiana corporation (\"Lilly\"), and Bald Eagle Acquisition Corporation, a Delaware corporation and a wholly owned subsidiary of Lilly (\"Merger Sub\"), Merger Sub merged with and into Dermira, with Dermira surviving as a wholly owned subsidiary of Lilly (the \"Merger\"), effective as of February 20, 2020.  Pursuant to the Merger Agreement, each issued and outstanding share (the \"Shares\") of Dermira common stock, par value $0.001 per share, was purchased at a price of $18.75 per share (the \"Offer Price\"), net to the seller in cash, without interest, and subject to withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each Dermira stock option, whether vested or unvested, was canceled and converted into the right to receive an amount in cash equal to the product of (x) the number of Shares issuable under such option multiplied by (y) the excess, if any, of (A) the Offer Price over (B) the per share exercise price of such option.  Any outstanding Dermira stock options with an exercise price equal to or greater than the Offer Price were canceled for no consideration at the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, immediately prior to the Effective Time, each Dermira stock option, whether vested or unvested, was canceled and converted into the right to receive an amount in cash equal to the product of (x) the number of Shares issuable under such option multiplied by (y) the excess, if any, of (A) the Offer Price over (B) the per share exercise price of such option.  Any outstanding Dermira stock options with an exercise price equal to or greater than the Offer Price were canceled for no consideration at the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":0.986,"expiration_date":"2021-10-03","underlying":"Common Stock","underlying_shares":110434},"source":{"system":"sec-edgar","filing":"0001562180-20-001621","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218020001621/primarydocument.xml","form_type":"4"}},{"id":3252500,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-02-24T19:32:23.000Z","date":"2020-02-20","kind":"disposition_to_issuer","acquired":false,"shares":16206,"price":18.75,"value":303862.5,"ownership":{"direct":false,"nature":"By the Bauer Family 1995 Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\") dated January 10, 2020, by and among Dermira, Inc. (\"Dermira\"), Eli Lilly and Company, an Indiana corporation (\"Lilly\"), and Bald Eagle Acquisition Corporation, a Delaware corporation and a wholly owned subsidiary of Lilly (\"Merger Sub\"), Merger Sub merged with and into Dermira, with Dermira surviving as a wholly owned subsidiary of Lilly (the \"Merger\"), effective as of February 20, 2020.  Pursuant to the Merger Agreement, each issued and outstanding share (the \"Shares\") of Dermira common stock, par value $0.001 per share, was purchased at a price of $18.75 per share (the \"Offer Price\"), net to the seller in cash, without interest, and subject to withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\") dated January 10, 2020, by and among Dermira, Inc. (\"Dermira\"), Eli Lilly and Company, an Indiana corporation (\"Lilly\"), and Bald Eagle Acquisition Corporation, a Delaware corporation and a wholly owned subsidiary of Lilly (\"Merger Sub\"), Merger Sub merged with and into Dermira, with Dermira surviving as a wholly owned subsidiary of Lilly (the \"Merger\"), effective as of February 20, 2020.  Pursuant to the Merger Agreement, each issued and outstanding share (the \"Shares\") of Dermira common stock, par value $0.001 per share, was purchased at a price of $18.75 per share (the \"Offer Price\"), net to the seller in cash, without interest, and subject to withholding taxes."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is a Co-Trustee."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-20-001621","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218020001621/primarydocument.xml","form_type":"4"}},{"id":3252499,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-02-24T19:32:23.000Z","date":"2020-02-20","kind":"disposition_to_issuer","acquired":false,"shares":3726,"price":18.75,"value":69862.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\") dated January 10, 2020, by and among Dermira, Inc. (\"Dermira\"), Eli Lilly and Company, an Indiana corporation (\"Lilly\"), and Bald Eagle Acquisition Corporation, a Delaware corporation and a wholly owned subsidiary of Lilly (\"Merger Sub\"), Merger Sub merged with and into Dermira, with Dermira surviving as a wholly owned subsidiary of Lilly (the \"Merger\"), effective as of February 20, 2020.  Pursuant to the Merger Agreement, each issued and outstanding share (the \"Shares\") of Dermira common stock, par value $0.001 per share, was purchased at a price of $18.75 per share (the \"Offer Price\"), net to the seller in cash, without interest, and subject to withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\") dated January 10, 2020, by and among Dermira, Inc. (\"Dermira\"), Eli Lilly and Company, an Indiana corporation (\"Lilly\"), and Bald Eagle Acquisition Corporation, a Delaware corporation and a wholly owned subsidiary of Lilly (\"Merger Sub\"), Merger Sub merged with and into Dermira, with Dermira surviving as a wholly owned subsidiary of Lilly (the \"Merger\"), effective as of February 20, 2020.  Pursuant to the Merger Agreement, each issued and outstanding share (the \"Shares\") of Dermira common stock, par value $0.001 per share, was purchased at a price of $18.75 per share (the \"Offer Price\"), net to the seller in cash, without interest, and subject to withholding taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-20-001621","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218020001621/primarydocument.xml","form_type":"4"}},{"id":3252498,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-02-24T19:32:23.000Z","date":"2020-02-11","kind":"gift","acquired":false,"shares":10772,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By the Bauer Family 1995 Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is a Co-Trustee."}],"balance_after":16206,"source":{"system":"sec-edgar","filing":"0001562180-20-001621","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218020001621/primarydocument.xml","form_type":"4"}},{"id":3252497,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-02-24T19:32:23.000Z","date":"2020-02-11","kind":"gift","acquired":false,"shares":12924,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3726,"source":{"system":"sec-edgar","filing":"0001562180-20-001621","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218020001621/primarydocument.xml","form_type":"4"}},{"id":3289117,"issuer":{"id":148532,"kind":"organization","name":"Aevi Genomic Medicine, LLC","symbol":"CERC"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2020-02-05T16:18:38.000Z","date":"2020-02-03","kind":"disposition_to_issuer","acquired":false,"shares":3530,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"This warrant, which was issued pursuant to a Securities Purchase Agreement dated August 9, 2017, was subsequently amended by the Amendment Agreement of Warrants to Purchase Common Stock dated December\n5, 2019, whereby immediately prior to the Merger the warrants were automatically exercised in a cashless exercise. Given the exercise price of the outstanding warrants, the cashless exercise resulted in no shares of common\nstock being issued and the warrant was rendered null and void."}],"balance_after":0,"derivative":{"exercise_price":2.84,"expiration_date":"2022-10-17","underlying":"Common Stock","underlying_shares":3530},"source":{"system":"sec-edgar","filing":"0001192482-20-000117","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1138776/000119248220000117/edgar.xml","form_type":"4"}},{"id":3289116,"issuer":{"id":148532,"kind":"organization","name":"Aevi Genomic Medicine, LLC","symbol":"CERC"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2020-02-05T16:18:38.000Z","date":"2020-02-03","kind":"disposition_to_issuer","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This option, which became exercisable on April 17, 2019, was automatically cancelled and ceased to exist without any consideration or payment pursuant to the Merger."}],"balance_after":0,"derivative":{"exercise_price":1.55,"expiration_date":"2028-04-17","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001192482-20-000117","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1138776/000119248220000117/edgar.xml","form_type":"4"}},{"id":3289115,"issuer":{"id":148532,"kind":"organization","name":"Aevi Genomic Medicine, LLC","symbol":"CERC"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2020-02-05T16:18:38.000Z","date":"2020-02-03","kind":"disposition_to_issuer","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option, which became exercisable on June 22, 2018, was automatically cancelled and ceased to exist without any consideration or payment pursuant to the Merger."}],"balance_after":0,"derivative":{"exercise_price":1.32,"expiration_date":"2027-06-22","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001192482-20-000117","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1138776/000119248220000117/edgar.xml","form_type":"4"}},{"id":3289114,"issuer":{"id":148532,"kind":"organization","name":"Aevi Genomic Medicine, LLC","symbol":"CERC"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2020-02-05T16:18:38.000Z","date":"2020-02-03","kind":"disposition_to_issuer","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option, which became exercisable on April 15, 2017, was automatically cancelled and ceased to exist without any consideration or payment pursuant to the Merger."}],"balance_after":0,"derivative":{"exercise_price":4.83,"expiration_date":"2026-04-15","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001192482-20-000117","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1138776/000119248220000117/edgar.xml","form_type":"4"}},{"id":3289113,"issuer":{"id":148532,"kind":"organization","name":"Aevi Genomic Medicine, LLC","symbol":"CERC"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2020-02-05T16:18:38.000Z","date":"2020-02-03","kind":"disposition_to_issuer","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option, which became exercisable on February 18, 2016, was automatically cancelled and ceased to exist without any consideration or payment pursuant to the Merger."}],"balance_after":0,"derivative":{"exercise_price":7.01,"expiration_date":"2025-02-18","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001192482-20-000117","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1138776/000119248220000117/edgar.xml","form_type":"4"}},{"id":3289112,"issuer":{"id":148532,"kind":"organization","name":"Aevi Genomic Medicine, LLC","symbol":"CERC"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2020-02-05T16:18:38.000Z","date":"2020-02-03","kind":"disposition_to_issuer","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option, which became exercisable on November 11, 2014, was automatically cancelled and ceased to exist without any consideration or payment pursuant to the Merger."}],"balance_after":0,"derivative":{"exercise_price":6.7,"expiration_date":"2023-11-11","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001192482-20-000117","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1138776/000119248220000117/edgar.xml","form_type":"4"}},{"id":3289111,"issuer":{"id":148532,"kind":"organization","name":"Aevi Genomic Medicine, LLC","symbol":"CERC"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2020-02-05T16:18:38.000Z","date":"2020-02-03","kind":"disposition_to_issuer","acquired":false,"shares":28571,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option, which became exercisable on Septmeber 14, 2011, was automatically cancelled and ceased to exist without any consideration or payment pursuant to the Merger."}],"balance_after":0,"derivative":{"exercise_price":8.19,"expiration_date":"2020-09-14","underlying":"Common Stock","underlying_shares":28571},"source":{"system":"sec-edgar","filing":"0001192482-20-000117","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1138776/000119248220000117/edgar.xml","form_type":"4"}},{"id":3289110,"issuer":{"id":148532,"kind":"organization","name":"Aevi Genomic Medicine, LLC","symbol":"CERC"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-05T16:18:38.000Z","date":"2020-02-03","kind":"disposition_to_issuer","acquired":false,"shares":165715,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of as a result of the merger pursuant to the previously announced Agreement and Plan of Merger and Reorganization by and among Cerecor Inc. (\"Cerecor\"), Genie Merger Sub, Inc., Second Genie Merger Sub, LLC and issuer (the \"Merger\").  At the effective time of the Merger, holders of issuer common stock received (A) the fraction of a share of Cerecor common stock equal to the exchange ratio of 0.0334 (B) one contingent value right, which represents the right to receive contingent payments upon the achievement of certain milestones and (C) cash in lieu of any fractional shares of Cerecor common stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001192482-20-000117","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1138776/000119248220000117/edgar.xml","form_type":"4"}},{"id":3434190,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2019-08-19T21:48:47.000Z","date":"2019-08-15","kind":"exercise","acquired":false,"shares":2625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one share of DERM common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Fully vested on August 15, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Fully vested on August 15, 2019."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2625},"source":{"system":"sec-edgar","filing":"0001562180-19-004390","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218019004390/primarydocument.xml","form_type":"4"}},{"id":3434189,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2019-08-19T21:48:47.000Z","date":"2019-08-15","kind":"exercise","acquired":false,"shares":2850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one share of DERM common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Vested as to 10% of the shares on August 15, 2018 and 30% of the shares on August 15, 2019. 30% of the shares will vest on each of August 15, 2020 and August 15, 2021, subject to the Reporting Person's continuous status as a service provider on the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Vested as to 10% of the shares on August 15, 2018 and 30% of the shares on August 15, 2019. 30% of the shares will vest on each of August 15, 2020 and August 15, 2021, subject to the Reporting Person's continuous status as a service provider on the applicable vesting date."}],"balance_after":5700,"derivative":{"underlying":"Common Stock","underlying_shares":2850},"source":{"system":"sec-edgar","filing":"0001562180-19-004390","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218019004390/primarydocument.xml","form_type":"4"}},{"id":3434188,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2019-08-19T21:48:47.000Z","date":"2019-08-15","kind":"exercise","acquired":false,"shares":2438,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one share of DERM common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Vested as to 10% of the shares on August 15, 2017 and 30% of the shares on each of August 15, 2018 and August 15, 2019. The remaining 30% of the shares will vest on August 15, 2020, subject to the Reporting Person's continuous status as a service provider on the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Vested as to 10% of the shares on August 15, 2017 and 30% of the shares on each of August 15, 2018 and August 15, 2019. The remaining 30% of the shares will vest on August 15, 2020, subject to the Reporting Person's continuous status as a service provider on the applicable vesting date."}],"balance_after":2437,"derivative":{"underlying":"Common Stock","underlying_shares":2438},"source":{"system":"sec-edgar","filing":"0001562180-19-004390","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218019004390/primarydocument.xml","form_type":"4"}},{"id":3434187,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-08-19T21:48:47.000Z","date":"2019-08-15","kind":"tax_withholding","acquired":false,"shares":986,"price":7.91,"value":7799.26,"ownership":{"direct":true},"balance_after":15329,"source":{"system":"sec-edgar","filing":"0001562180-19-004390","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218019004390/primarydocument.xml","form_type":"4"}},{"id":3434186,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-08-19T21:48:47.000Z","date":"2019-08-15","kind":"tax_withholding","acquired":false,"shares":908,"price":7.91,"value":7182.28,"ownership":{"direct":true},"balance_after":16315,"source":{"system":"sec-edgar","filing":"0001562180-19-004390","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218019004390/primarydocument.xml","form_type":"4"}},{"id":3434185,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-08-19T21:48:47.000Z","date":"2019-08-15","kind":"tax_withholding","acquired":false,"shares":844,"price":7.91,"value":6676.04,"ownership":{"direct":true},"balance_after":17223,"source":{"system":"sec-edgar","filing":"0001562180-19-004390","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218019004390/primarydocument.xml","form_type":"4"}},{"id":3434184,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-08-19T21:48:47.000Z","date":"2019-08-15","kind":"exercise","acquired":true,"shares":2625,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":18067,"source":{"system":"sec-edgar","filing":"0001562180-19-004390","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218019004390/primarydocument.xml","form_type":"4"}},{"id":3434183,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-08-19T21:48:47.000Z","date":"2019-08-15","kind":"exercise","acquired":true,"shares":2850,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":15442,"source":{"system":"sec-edgar","filing":"0001562180-19-004390","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218019004390/primarydocument.xml","form_type":"4"}},{"id":3434182,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-08-19T21:48:47.000Z","date":"2019-08-15","kind":"exercise","acquired":true,"shares":2438,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include prior ESPP purchases."}],"balance_after":12592,"source":{"system":"sec-edgar","filing":"0001562180-19-004390","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218019004390/primarydocument.xml","form_type":"4"}},{"id":3559197,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Options (Right to buy)","published_at":"2019-04-09T16:40:04.000Z","date":"2019-04-08","kind":"exercise","acquired":false,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option fully vested on 1/4/2017."}],"balance_after":103258,"derivative":{"exercise_price":1.218,"expiration_date":"2023-01-03","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001562180-19-002245","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218019002245/primarydocument.xml","form_type":"4"}},{"id":3559196,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-04-09T16:40:04.000Z","date":"2019-04-08","kind":"sale","acquired":false,"shares":35000,"price":15,"value":525000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include prior ESPP purchases."}],"balance_after":8900,"source":{"system":"sec-edgar","filing":"0001562180-19-002245","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218019002245/primarydocument.xml","form_type":"4"}},{"id":3559195,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-04-09T16:40:04.000Z","date":"2019-04-08","kind":"exercise","acquired":true,"shares":35000,"price":1.218,"value":42630.0,"ownership":{"direct":true},"balance_after":43900,"source":{"system":"sec-edgar","filing":"0001562180-19-002245","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218019002245/primarydocument.xml","form_type":"4"}},{"id":3656145,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2019-02-14T19:57:29.000Z","date":"2019-02-12","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of DERM common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Vests as to 50% of the shares on March 5, 2020, 50% on March 5, 2021, subject to the continuing employment of the Reporting Person on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Vests as to 50% of the shares on March 5, 2020, 50% on March 5, 2021, subject to the continuing employment of the Reporting Person on each vesting date."}],"balance_after":15000,"derivative":{"underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001562180-19-000996","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218019000996/primarydocument.xml","form_type":"4"}},{"id":3656144,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Options (Right to buy)","published_at":"2019-02-14T19:57:29.000Z","date":"2019-02-12","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests and becomes exercisable as to 1/48th of the shares in equal monthly installments with the first 1/48th of the shares vesting on February 1, 2019, subject to the continuing employment of the Reporting person on the applicable vesting date."}],"balance_after":65000,"derivative":{"exercise_price":7.42,"expiration_date":"2029-02-11","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001562180-19-000996","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218019000996/primarydocument.xml","form_type":"4"}},{"id":3819356,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2018-09-11T16:42:41.000Z","date":"2018-08-15","kind":"exercise","acquired":false,"shares":2625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one share of DERM common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Vested as to 10% of the shares on August 15, 2016 and 30% of the shares on each of August 15, 2017 and August 15, 2018.  The remaining 30% of the shares will vest on August 15, 2019, subject to the Reporting Person's continuous status as a service provider on the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Vested as to 10% of the shares on August 15, 2016 and 30% of the shares on each of August 15, 2017 and August 15, 2018.  The remaining 30% of the shares will vest on August 15, 2019, subject to the Reporting Person's continuous status as a service provider on the vesting date."}],"balance_after":2625,"derivative":{"underlying":"Common Stock","underlying_shares":2625},"source":{"system":"sec-edgar","filing":"0001562180-18-003904","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218018003904/primarydocument.xml","form_type":"4/A","original_submission_date":"2018-08-16"}},{"id":3819355,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2018-09-11T16:42:41.000Z","date":"2018-08-15","kind":"exercise","acquired":false,"shares":2437,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one share of DERM common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Vested as to 10% of the shares on August 15, 2017 and 30% of the shares on August 15, 2018.  30% of the shares will vest on each of August 15, 2019 and August 15, 2020, subject to the Reporting Person's continuous status as a service provider on the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Vested as to 10% of the shares on August 15, 2017 and 30% of the shares on August 15, 2018.  30% of the shares will vest on each of August 15, 2019 and August 15, 2020, subject to the Reporting Person's continuous status as a service provider on the applicable vesting date."}],"balance_after":4875,"derivative":{"underlying":"Common Stock","underlying_shares":2437},"source":{"system":"sec-edgar","filing":"0001562180-18-003904","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218018003904/primarydocument.xml","form_type":"4/A","original_submission_date":"2018-08-16"}},{"id":3819354,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2018-09-11T16:42:41.000Z","date":"2018-08-15","kind":"exercise","acquired":false,"shares":950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one share of DERM common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Vested as to 10% of the shares on August 15, 2018. 30% of the shares will vest on each of August 15, 2019, August 15, 2020 and August 15, 2021, subject to the Reporting Person's continuous status as a service provider on the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Vested as to 10% of the shares on August 15, 2018. 30% of the shares will vest on each of August 15, 2019, August 15, 2020 and August 15, 2021, subject to the Reporting Person's continuous status as a service provider on the applicable vesting date."}],"balance_after":8550,"derivative":{"underlying":"Common Stock","underlying_shares":950},"source":{"system":"sec-edgar","filing":"0001562180-18-003904","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218018003904/primarydocument.xml","form_type":"4/A","original_submission_date":"2018-08-16"}},{"id":3819353,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-09-11T16:42:41.000Z","date":"2018-08-15","kind":"tax_withholding","acquired":false,"shares":908,"price":9.58,"value":8698.64,"ownership":{"direct":true},"balance_after":7751,"source":{"system":"sec-edgar","filing":"0001562180-18-003904","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218018003904/primarydocument.xml","form_type":"4/A","original_submission_date":"2018-08-16"}},{"id":3819352,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-09-11T16:42:41.000Z","date":"2018-08-15","kind":"tax_withholding","acquired":false,"shares":843,"price":9.58,"value":8075.94,"ownership":{"direct":true},"balance_after":8659,"source":{"system":"sec-edgar","filing":"0001562180-18-003904","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218018003904/primarydocument.xml","form_type":"4/A","original_submission_date":"2018-08-16"}},{"id":3819351,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-09-11T16:42:41.000Z","date":"2018-08-15","kind":"tax_withholding","acquired":false,"shares":329,"price":9.58,"value":3151.82,"ownership":{"direct":true},"balance_after":9502,"source":{"system":"sec-edgar","filing":"0001562180-18-003904","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218018003904/primarydocument.xml","form_type":"4/A","original_submission_date":"2018-08-16"}},{"id":3819350,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-09-11T16:42:41.000Z","date":"2018-08-15","kind":"exercise","acquired":true,"shares":2625,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9831,"source":{"system":"sec-edgar","filing":"0001562180-18-003904","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218018003904/primarydocument.xml","form_type":"4/A","original_submission_date":"2018-08-16"}},{"id":3819349,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-09-11T16:42:41.000Z","date":"2018-08-15","kind":"exercise","acquired":true,"shares":2437,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7206,"source":{"system":"sec-edgar","filing":"0001562180-18-003904","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218018003904/primarydocument.xml","form_type":"4/A","original_submission_date":"2018-08-16"}},{"id":3819348,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-09-11T16:42:41.000Z","date":"2018-08-15","kind":"exercise","acquired":true,"shares":950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include prior ESPP purchases."}],"balance_after":4769,"source":{"system":"sec-edgar","filing":"0001562180-18-003904","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218018003904/primarydocument.xml","form_type":"4/A","original_submission_date":"2018-08-16"}},{"id":3839640,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2018-08-17T16:05:15.000Z","date":"2018-08-15","kind":"exercise","acquired":false,"shares":2625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one share of DERM common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Vested as to 10% of the shares on August 15, 2016 and 30% of the shares on each of August 15, 2017 and August 15, 2018.  The remaining 30% of the shares will vest on August 15, 2019, subject to the Reporting Person's continuous status as a service provider on the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Vested as to 10% of the shares on August 15, 2016 and 30% of the shares on each of August 15, 2017 and August 15, 2018.  The remaining 30% of the shares will vest on August 15, 2019, subject to the Reporting Person's continuous status as a service provider on the vesting date."}],"balance_after":2625,"derivative":{"underlying":"Common Stock","underlying_shares":2625},"source":{"system":"sec-edgar","filing":"0001562180-18-003668","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218018003668/primarydocument.xml","form_type":"4"}},{"id":3839639,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2018-08-17T16:05:15.000Z","date":"2018-08-15","kind":"exercise","acquired":false,"shares":2437,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one share of DERM common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Vested as to 10% of the shares on August 15, 2017 and 30% of the shares on August 15, 2018.  30% of the shares will vest on each of August 15, 2019 and August 15, 2020, subject to the Reporting Person's continuous status as a service provider on the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Vested as to 10% of the shares on August 15, 2017 and 30% of the shares on August 15, 2018.  30% of the shares will vest on each of August 15, 2019 and August 15, 2020, subject to the Reporting Person's continuous status as a service provider on the applicable vesting date."}],"balance_after":4875,"derivative":{"underlying":"Common Stock","underlying_shares":2437},"source":{"system":"sec-edgar","filing":"0001562180-18-003668","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218018003668/primarydocument.xml","form_type":"4"}},{"id":3839638,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2018-08-17T16:05:15.000Z","date":"2018-08-15","kind":"exercise","acquired":false,"shares":950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one share of DERM common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Vested as to 10% of the shares on August 15, 2018. 30% of the shares will vest on each of August 15, 2019, August 15, 2020 and August 15, 2021, subject to the Reporting Person's continuous status as a service provider on the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Vested as to 10% of the shares on August 15, 2018. 30% of the shares will vest on each of August 15, 2019, August 15, 2020 and August 15, 2021, subject to the Reporting Person's continuous status as a service provider on the applicable vesting date."}],"balance_after":8550,"derivative":{"underlying":"Common Stock","underlying_shares":950},"source":{"system":"sec-edgar","filing":"0001562180-18-003668","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218018003668/primarydocument.xml","form_type":"4"}},{"id":3839637,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2018-08-17T16:05:15.000Z","date":"2018-08-15","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one share of DERM common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Vests as to 50% of the shares on each of May 17, 2019 and May 17, 2020, subject to the Reporting Person's continuous status as a service provider on the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Vests as to 50% of the shares on each of May 17, 2019 and May 17, 2020, subject to the Reporting Person's continuous status as a service provider on the applicable vesting date."}],"balance_after":50000,"derivative":{"underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001562180-18-003668","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218018003668/primarydocument.xml","form_type":"4"}},{"id":3839636,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-08-17T16:05:15.000Z","date":"2018-08-15","kind":"tax_withholding","acquired":false,"shares":908,"price":9.58,"value":8698.64,"ownership":{"direct":true},"balance_after":7751,"source":{"system":"sec-edgar","filing":"0001562180-18-003668","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218018003668/primarydocument.xml","form_type":"4"}},{"id":3839635,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-08-17T16:05:15.000Z","date":"2018-08-15","kind":"tax_withholding","acquired":false,"shares":843,"price":9.58,"value":8075.94,"ownership":{"direct":true},"balance_after":8659,"source":{"system":"sec-edgar","filing":"0001562180-18-003668","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218018003668/primarydocument.xml","form_type":"4"}},{"id":3839634,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-08-17T16:05:15.000Z","date":"2018-08-15","kind":"tax_withholding","acquired":false,"shares":329,"price":9.58,"value":3151.82,"ownership":{"direct":true},"balance_after":9502,"source":{"system":"sec-edgar","filing":"0001562180-18-003668","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218018003668/primarydocument.xml","form_type":"4"}},{"id":3839633,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-08-17T16:05:15.000Z","date":"2018-08-15","kind":"exercise","acquired":true,"shares":2625,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9831,"source":{"system":"sec-edgar","filing":"0001562180-18-003668","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218018003668/primarydocument.xml","form_type":"4"}},{"id":3839632,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-08-17T16:05:15.000Z","date":"2018-08-15","kind":"exercise","acquired":true,"shares":2437,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7206,"source":{"system":"sec-edgar","filing":"0001562180-18-003668","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218018003668/primarydocument.xml","form_type":"4"}},{"id":3839631,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-08-17T16:05:15.000Z","date":"2018-08-15","kind":"exercise","acquired":true,"shares":950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include prior ESPP purchases."}],"balance_after":4769,"source":{"system":"sec-edgar","filing":"0001562180-18-003668","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218018003668/primarydocument.xml","form_type":"4"}},{"id":3865485,"issuer":{"id":148532,"kind":"organization","name":"Aevi Genomic Medicine, LLC","symbol":"CERC"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2018-07-18T16:21:34.000Z","date":"2018-06-14","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option award was granted on April 17, 2018 and was subject to forfeiture if stockholder approval of a proposed amendment to the Issuer's stock incentive plan to increase the number of shares reserved for issuance under the plan was not obtained. The Issuer's stockholders approved the amendment to the Issuer's stock incentive plan at the Issuer's annual meeting of stockholders on June 14, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This amendment is being filed to amend the vesting schedule of the option award. The entire option vests and becomes exercisable on April 17, 2019, subject to the reporting person's continued service with the Issuer."}],"balance_after":50000,"derivative":{"exercise_price":1.55,"expiration_date":"2028-04-17","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001192482-18-000344","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1138776/000119248218000344/edgar.xml","form_type":"4/A","original_submission_date":"2018-06-18"}},{"id":3890952,"issuer":{"id":148532,"kind":"organization","name":"Aevi Genomic Medicine, LLC","symbol":"CERC"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2018-06-18T16:18:54.000Z","date":"2018-06-14","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option award was granted on April 17, 2018 and was subject to forfeiture if stockholder approval of a proposed amendment to the Issuer's stock incentive plan to increase the number of shares reserved for issuance under the plan was not obtained. The Issuer's stockholders approved the amendment to the Issuer's stock incentive plan at the Issuer's annual meeting of stockholders on June 14, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option award vests and becomes exercisable as follows (rounded up to the nearest whole share of common stock): one-third on April 17, 2019, then in 24 equal monthly installments on the 17th day of each subsequent calendar month, subject to the reporting person's continued service with the issuer."}],"balance_after":50000,"derivative":{"exercise_price":1.55,"expiration_date":"2028-04-17","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001192482-18-000299","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1138776/000119248218000299/edgar.xml","form_type":"4"}},{"id":3969436,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-04-04T14:31:07.000Z","date":"2018-03-31","kind":"grant","acquired":true,"shares":2262,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2262,"derivative":{"exercise_price":4.29,"exercise_date":"2018-03-31","expiration_date":"2028-03-30","underlying":"Common Stock","underlying_shares":2262},"source":{"system":"sec-edgar","filing":"0001562180-18-001826","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218018001826/primarydocument.xml","form_type":"4"}},{"id":4010310,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Options (Right to buy)","published_at":"2018-03-06T16:04:27.000Z","date":"2018-03-02","kind":"exercise","acquired":false,"shares":2500,"price":1.218,"value":3045.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option fully vested on 1/4/2017."}],"balance_after":8972,"derivative":{"exercise_price":1.218,"expiration_date":"2023-01-03","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001562180-18-001486","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218018001486/primarydocument.xml","form_type":"4"}},{"id":4010309,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-03-06T16:04:27.000Z","date":"2018-03-02","kind":"sale","acquired":false,"shares":2500,"price":25,"value":62500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $25.00 to $25.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include prior ESPP purchases."}],"balance_after":2802,"source":{"system":"sec-edgar","filing":"0001562180-18-001486","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218018001486/primarydocument.xml","form_type":"4"}},{"id":4010308,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-03-06T16:04:27.000Z","date":"2018-03-02","kind":"exercise","acquired":true,"shares":2500,"price":1.218,"value":3045.0,"ownership":{"direct":true},"balance_after":5302,"source":{"system":"sec-edgar","filing":"0001562180-18-001486","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218018001486/primarydocument.xml","form_type":"4"}},{"id":4019472,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Options (Right to buy)","published_at":"2018-03-02T16:25:36.000Z","date":"2018-03-01","kind":"exercise","acquired":false,"shares":500,"price":1.218,"value":609.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option fully vested on 1/4/2017."}],"balance_after":11472,"derivative":{"exercise_price":1.218,"expiration_date":"2023-01-03","underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001562180-18-001390","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218018001390/primarydocument.xml","form_type":"4"}},{"id":4019471,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-03-02T16:25:36.000Z","date":"2018-03-01","kind":"sale","acquired":false,"shares":500,"price":25.316,"value":12658.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $25.00 to $25.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include prior ESPP purchases."}],"balance_after":2802,"source":{"system":"sec-edgar","filing":"0001562180-18-001390","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218018001390/primarydocument.xml","form_type":"4"}},{"id":4019470,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-03-02T16:25:36.000Z","date":"2018-03-01","kind":"exercise","acquired":true,"shares":500,"price":1.218,"value":609.0,"ownership":{"direct":true},"balance_after":3302,"source":{"system":"sec-edgar","filing":"0001562180-18-001390","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218018001390/primarydocument.xml","form_type":"4"}},{"id":4051427,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2018-02-16T17:37:27.000Z","date":"2018-02-15","kind":"grant","acquired":true,"shares":9500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of DERM common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Vests as to 10% of the shares on August 15, 2018, 30% on August 15, 2019, 30% on August 15, 2020, 30% on August 15,2021, subject to the continuing employment of the Reporting Person on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each RSU represents a contingent right to receive one share of DERM common stock."}],"balance_after":9500,"derivative":{"underlying":"Common Stock","underlying_shares":9500},"source":{"system":"sec-edgar","filing":"0001562180-18-001048","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218018001048/primarydocument.xml","form_type":"4"}},{"id":4051426,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Options (Right to buy)","published_at":"2018-02-16T17:37:27.000Z","date":"2018-02-15","kind":"grant","acquired":true,"shares":57000,"price":28.25,"value":1610250.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests and becomes exercisable as to 1/48th of the shares in equal monthly installments with the first 1/48th of the shares vesting on January 1, 2018, subject to the continuing employment of the Reporting person on the applicable vesting date."}],"balance_after":57000,"derivative":{"exercise_price":28.25,"expiration_date":"2028-02-15","underlying":"Common Stock","underlying_shares":57000},"source":{"system":"sec-edgar","filing":"0001562180-18-001048","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218018001048/primarydocument.xml","form_type":"4"}},{"id":4078822,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Options (Right to buy)","published_at":"2018-02-02T16:46:08.000Z","date":"2018-02-01","kind":"exercise","acquired":false,"shares":3000,"price":1.218,"value":3654.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option fully vested on 1/4/2017."}],"balance_after":11972,"derivative":{"exercise_price":1.218,"expiration_date":"2023-01-03","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001562180-18-000591","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218018000591/primarydocument.xml","form_type":"4"}},{"id":4078821,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-02-02T16:46:08.000Z","date":"2018-02-01","kind":"sale","acquired":false,"shares":3000,"price":28.5473,"value":85641.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $28.26 to $28.97. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include prior ESPP purchases."}],"balance_after":2802,"source":{"system":"sec-edgar","filing":"0001562180-18-000591","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218018000591/primarydocument.xml","form_type":"4"}},{"id":4078820,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-02-02T16:46:08.000Z","date":"2018-02-01","kind":"exercise","acquired":true,"shares":3000,"price":1.218,"value":3654.0,"ownership":{"direct":true},"balance_after":5802,"source":{"system":"sec-edgar","filing":"0001562180-18-000591","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218018000591/primarydocument.xml","form_type":"4"}},{"id":4107030,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Options (Right to buy)","published_at":"2018-01-04T16:16:19.000Z","date":"2018-01-02","kind":"exercise","acquired":false,"shares":1976,"price":1.218,"value":2406.768,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option fully vested on 1/4/2017."}],"balance_after":14972,"derivative":{"exercise_price":1.218,"expiration_date":"2023-01-03","underlying":"Common Stock","underlying_shares":1976},"source":{"system":"sec-edgar","filing":"0001562180-18-000202","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218018000202/primarydocument.xml","form_type":"4"}},{"id":4107029,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-01-04T16:16:19.000Z","date":"2018-01-02","kind":"sale","acquired":false,"shares":100,"price":28.03,"value":2803.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":2802,"source":{"system":"sec-edgar","filing":"0001562180-18-000202","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218018000202/primarydocument.xml","form_type":"4"}},{"id":4107028,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-01-04T16:16:19.000Z","date":"2018-01-02","kind":"sale","acquired":false,"shares":2900,"price":27.0368,"value":78406.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $26.65 to $27.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include prior ESPP purchases."}],"balance_after":2902,"source":{"system":"sec-edgar","filing":"0001562180-18-000202","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218018000202/primarydocument.xml","form_type":"4"}},{"id":4107027,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-01-04T16:16:19.000Z","date":"2018-01-02","kind":"exercise","acquired":true,"shares":1976,"price":1.218,"value":2406.768,"ownership":{"direct":true},"balance_after":5802,"source":{"system":"sec-edgar","filing":"0001562180-18-000202","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218018000202/primarydocument.xml","form_type":"4"}},{"id":4107026,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-01-04T10:18:27.000Z","date":"2017-12-31","kind":"grant","acquired":true,"shares":3060,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3060,"derivative":{"exercise_price":3.2,"exercise_date":"2017-12-31","expiration_date":"2027-12-30","underlying":"Common Stock","underlying_shares":3060},"source":{"system":"sec-edgar","filing":"0001562180-18-000177","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218018000177/primarydocument.xml","form_type":"4"}},{"id":4124824,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-12-20T16:15:37.000Z","date":"2017-12-18","kind":"sale","acquired":false,"shares":3000,"price":27.3369,"value":82010.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $27.15 to $27.56. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"These shares include prior ESPP purchases."}],"balance_after":3826,"source":{"system":"sec-edgar","filing":"0001562180-17-003974","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218017003974/primarydocument.xml","form_type":"4"}},{"id":4184118,"issuer":{"id":148532,"kind":"organization","name":"Aevi Genomic Medicine, LLC","symbol":"CERC"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2017-10-18T16:17:29.000Z","date":"2017-10-17","kind":"purchase","acquired":true,"shares":3530,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3530,"derivative":{"exercise_price":2.84,"exercise_date":"2017-10-17","expiration_date":"2022-10-17","underlying":"Common Stock","underlying_shares":3530},"source":{"system":"sec-edgar","filing":"0001144204-17-053031","document":"tv477170_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1138776/000114420417053031/tv477170_4.xml","form_type":"4"}},{"id":4184117,"issuer":{"id":148532,"kind":"organization","name":"Aevi Genomic Medicine, LLC","symbol":"CERC"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-18T16:17:29.000Z","date":"2017-10-17","kind":"purchase","acquired":true,"shares":19841,"price":1.26,"value":24999.66,"ownership":{"direct":true},"balance_after":165715,"source":{"system":"sec-edgar","filing":"0001144204-17-053031","document":"tv477170_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1138776/000114420417053031/tv477170_4.xml","form_type":"4"}},{"id":4186495,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-10-13T11:40:51.000Z","date":"2017-10-11","kind":"sale","acquired":false,"shares":7500,"price":30.04,"value":225300.0,"ownership":{"direct":false,"nature":"By the Bauer Family 1995 Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $30.00 to $30.17. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is a Co-Trustee."}],"balance_after":26978,"source":{"system":"sec-edgar","filing":"0001562180-17-003260","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218017003260/primarydocument.xml","form_type":"4"}},{"id":4191853,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-10-04T14:22:00.000Z","date":"2017-09-30","kind":"grant","acquired":true,"shares":10202,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10202,"derivative":{"exercise_price":0.85,"exercise_date":"2017-09-30","expiration_date":"2027-09-29","underlying":"Common Stock","underlying_shares":10202},"source":{"system":"sec-edgar","filing":"0001562180-17-003187","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218017003187/primarydocument.xml","form_type":"4"}},{"id":4230481,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2017-08-17T19:44:54.000Z","date":"2017-08-15","kind":"exercise","acquired":false,"shares":813,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one share of DERM common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Vested as to 10% of the shares on August 15, 2017. 30% of the shares will vest on each of August 15, 2018, August 15, 2019 and August 15, 2020, subject to the Reporting Person's continuous status as a service provider on the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Vested as to 10% of the shares on August 15, 2017. 30% of the shares will vest on each of August 15, 2018, August 15, 2019 and August 15, 2020, subject to the Reporting Person's continuous status as a service provider on the applicable vesting date."}],"balance_after":7312,"derivative":{"underlying":"Common Stock","underlying_shares":813},"source":{"system":"sec-edgar","filing":"0001562180-17-002757","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218017002757/primarydocument.xml","form_type":"4"}},{"id":4230480,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2017-08-17T19:44:54.000Z","date":"2017-08-15","kind":"exercise","acquired":false,"shares":2625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one share of DERM common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Vested as to 10% of the shares on August 15, 2016 and 30% of the shares on August 15, 2017. 30% of the shares will vest on each of August 15, 2018 and August 15, 2019, subject to the Reporting Person's continuous status as a service provider on the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Vested as to 10% of the shares on August 15, 2016 and 30% of the shares on August 15, 2017. 30% of the shares will vest on each of August 15, 2018 and August 15, 2019, subject to the Reporting Person's continuous status as a service provider on the applicable vesting date."}],"balance_after":5250,"derivative":{"underlying":"Common Stock","underlying_shares":2625},"source":{"system":"sec-edgar","filing":"0001562180-17-002757","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218017002757/primarydocument.xml","form_type":"4"}},{"id":4230479,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-08-17T19:44:54.000Z","date":"2017-08-15","kind":"tax_withholding","acquired":false,"shares":306,"price":23.58,"value":7215.48,"ownership":{"direct":true},"balance_after":6360,"source":{"system":"sec-edgar","filing":"0001562180-17-002757","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218017002757/primarydocument.xml","form_type":"4"}},{"id":4230478,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-08-17T19:44:54.000Z","date":"2017-08-15","kind":"tax_withholding","acquired":false,"shares":987,"price":23.58,"value":23273.46,"ownership":{"direct":true},"balance_after":6666,"source":{"system":"sec-edgar","filing":"0001562180-17-002757","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218017002757/primarydocument.xml","form_type":"4"}},{"id":4230477,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-08-17T19:44:54.000Z","date":"2017-08-15","kind":"exercise","acquired":true,"shares":2625,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7653,"source":{"system":"sec-edgar","filing":"0001562180-17-002757","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218017002757/primarydocument.xml","form_type":"4"}},{"id":4230476,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-08-17T19:44:54.000Z","date":"2017-08-15","kind":"exercise","acquired":true,"shares":813,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares include prior ESPP purchases."}],"balance_after":5028,"source":{"system":"sec-edgar","filing":"0001562180-17-002757","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218017002757/primarydocument.xml","form_type":"4"}},{"id":4237939,"issuer":{"id":148532,"kind":"organization","name":"Aevi Genomic Medicine, LLC","symbol":"CERC"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option Award (right to buy)","published_at":"2017-08-10T21:25:51.000Z","date":"2017-06-22","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20000,"derivative":{"exercise_price":1.32,"exercise_date":"2018-06-22","expiration_date":"2027-06-22","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001144204-17-042175","document":"v472998_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1138776/000114420417042175/v472998_form4.xml","form_type":"4"}},{"id":4248327,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-07-31T13:34:00.000Z","date":"2017-06-30","kind":"grant","acquired":true,"shares":8357,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest in full on June 30, 2018, subject to the grantees continued service on such vesting date."}],"balance_after":8357,"derivative":{"exercise_price":0.57,"exercise_date":"2018-06-30","expiration_date":"2027-06-29","underlying":"Common Stock","underlying_shares":8357},"source":{"system":"sec-edgar","filing":"0001562180-17-002530","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218017002530/primarydocument.xml","form_type":"4"}},{"id":4261588,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-07-06T16:13:28.000Z","date":"2017-07-05","kind":"sale","acquired":false,"shares":2500,"price":30.003,"value":75007.5,"ownership":{"direct":false,"nature":"By the Bauer Family 1995 Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $30.00 to $30.035. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is a Co-Trustee."}],"balance_after":34478,"source":{"system":"sec-edgar","filing":"0001562180-17-002454","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218017002454/primarydocument.xml","form_type":"4"}},{"id":4263660,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-07-05T13:38:59.000Z","date":"2017-06-30","kind":"grant","acquired":true,"shares":13690,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vested immediately and became exercisable in full upon grant on 6/30/2017."}],"balance_after":13690,"derivative":{"exercise_price":0.57,"exercise_date":"2017-06-30","expiration_date":"2027-06-29","underlying":"Common Stock","underlying_shares":13690},"source":{"system":"sec-edgar","filing":"0001562180-17-002384","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218017002384/primarydocument.xml","form_type":"4"}},{"id":4275153,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-06-21T17:03:03.000Z","date":"2017-06-20","kind":"sale","acquired":false,"shares":2500,"price":30.0128,"value":75032.0,"ownership":{"direct":false,"nature":"By the Bauer Family 1995 Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $30.00 to $30.07. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is a Co-Trustee."}],"balance_after":36978,"source":{"system":"sec-edgar","filing":"0001562180-17-002302","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218017002302/primarydocument.xml","form_type":"4"}},{"id":4334859,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-05-03T16:07:07.000Z","date":"2017-05-01","kind":"sale","acquired":false,"shares":2500,"price":33.6463,"value":84115.75,"ownership":{"direct":false,"nature":"By the Bauer Family 1995 Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $33.39 to $34.24. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is a Co-Trustee."}],"balance_after":39478,"source":{"system":"sec-edgar","filing":"0001562180-17-001702","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218017001702/primarydocument.xml","form_type":"4"}},{"id":4360275,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-04-04T17:38:46.000Z","date":"2017-04-03","kind":"sale","acquired":false,"shares":521,"price":34.0309,"value":17730.0989,"ownership":{"direct":false,"nature":"By the Bauer Family 1995 Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $33.99 to $34.11. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is a Co-Trustee."}],"balance_after":41978,"source":{"system":"sec-edgar","filing":"0001562180-17-001441","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218017001441/primarydocument.xml","form_type":"4"}},{"id":4360274,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-04-04T17:38:46.000Z","date":"2017-04-03","kind":"sale","acquired":false,"shares":1979,"price":33.4039,"value":66106.3181,"ownership":{"direct":false,"nature":"By the Bauer Family 1995 Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $32.97 to $33.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is a Co-Trustee."}],"balance_after":42499,"source":{"system":"sec-edgar","filing":"0001562180-17-001441","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218017001441/primarydocument.xml","form_type":"4"}},{"id":4360333,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-04-04T14:02:21.000Z","date":"2017-03-31","kind":"grant","acquired":true,"shares":9751,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9751,"derivative":{"exercise_price":0.68,"exercise_date":"2017-03-31","expiration_date":"2027-03-30","underlying":"Common Stock","underlying_shares":9751},"source":{"system":"sec-edgar","filing":"0001562180-17-001402","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218017001402/primarydocument.xml","form_type":"4"}},{"id":4408821,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-03-02T19:12:27.000Z","date":"2017-03-01","kind":"sale","acquired":false,"shares":100,"price":35.89,"value":3589.0,"ownership":{"direct":false,"nature":"By the Bauer Family 1995 Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is a Co-Trustee."}],"balance_after":44478,"source":{"system":"sec-edgar","filing":"0001562180-17-001070","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218017001070/primarydocument.xml","form_type":"4"}},{"id":4408820,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-03-02T19:12:27.000Z","date":"2017-03-01","kind":"sale","acquired":false,"shares":400,"price":34.4875,"value":13795.0,"ownership":{"direct":false,"nature":"By the Bauer Family 1995 Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $34.42 to $34.59. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is a Co-Trustee."}],"balance_after":44578,"source":{"system":"sec-edgar","filing":"0001562180-17-001070","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218017001070/primarydocument.xml","form_type":"4"}},{"id":4408819,"issuer":{"id":11896,"kind":"organization","name":"Dermira, Inc.","symbol":"DERM"},"owners":[{"id":130496,"kind":"person","name":"BAUER EUGENE A","position":1,"cik":"0001210524","reported_name":"BAUER EUGENE A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-03-02T19:12:27.000Z","date":"2017-03-01","kind":"sale","acquired":false,"shares":1200,"price":33.8075,"value":40569.0,"ownership":{"direct":false,"nature":"By the Bauer Family 1995 Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These trades were made pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $33.41 to $34.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is a Co-Trustee."}],"balance_after":44978,"source":{"system":"sec-edgar","filing":"0001562180-17-001070","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1210524/000156218017001070/primarydocument.xml","form_type":"4"}}],"next_cursor":"2017-03-02T19:12:27.000000Z,4408819"}